Clinicopathological characterisation of small (2cm or less) proximal and distal gastric carcinomas in a Chinese population

Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Gregory Y. Lauwers(Moffitt Cancer Center), Yifen Zhang(Nanjing University of Chinese Medicine), Jason S. Gold(Memorial Sloan Kettering Cancer Center), Wenyan Guan(Nanjing Drum Tower Hospital), Hiroshi Mashimo(VA Boston Healthcare System), Travis Manasco(Boston Medical Center), Hongyan Wu(Hong Kong Baptist University), Jieyu Chen(Nanjing Drum Tower Hospital), Huiping Yu(Nanjing Drum Tower Hospital), Chenggong Yu(Nanjing Drum Tower Hospital), Qi Sun(Fudan University), Jiong Shi(Nanjing Drum Tower Hospital)
Pathology
July 11, 2015
10.1097/pat.0000000000000276
Cited by 40

Related Papers

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
|Journal of Clinical Oncology|2009|507